Valproate as an antidepressant in major depressive disorder.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Psychopharmacology bulletin

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 8993086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of sodium valproate on mania

  2004cited by this paper
• Results of the DSM-IV mood disorders field trial.

  1995cited by this paper
• Benzodiazepines as antidepressants: does GABA play a role in depression?

  1995cited by this paper
• GABA and mood disorders: a brief review and hypothesis.

  1995cited by this paper
• Plasma concentrations of gamma-aminobutyric acid (GABA) and mood disorders: a blood test for manic depressive disease?

  1994cited by this paper
• Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.

  1994cited by this paper
• Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome.

  1993cited by this paper
• Differential effects of olfactory bulbectomy on GABAA and GABAB receptors in the rat brain.

  1993cited by this paper
• Rapid cycling bipolar disorder and its treatment with valproate.

  1993cited by this paper
• The role of carbamazepine in the prophylaxis of unipolar depression.

  1993cited by this paper
• Low plasma gamma-aminobutyric acid levels in male patients with depression.

  1992cited by this paper
• Brain GABAB binding sites in depressed suicide victims.

  1988cited by this paper
• Intracortical glutamate injection produces helpless-like behavior in the rat.

  1985cited by this paper
• GABAergic modulation of learned helplessness.

  1981cited by this paper
• Central actions of valproic acid in man and in experimental models of epilepsy.

  1981cited by this paper
• A RATING SCALE FOR DEPRESSION

  1960cited by this paper

• Lithium increases mitochondrial respiration in iPSC-derived neural precursor cells from lithium responders

  2021cites this paper
• The Association Between Vascular Inflammation and Depressive Disorder. Causality, Biomarkers and Targeted Treatment

  2020cites this paper
• Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines

  2020cites this paper
• The role of gamma-aminobutyric acid in female depression

  2019cites this paper
• The role of gamma-aminobutyric acid in female depression

  2017cites this paper
• Dysfunction of Microglial STAT3 Alleviates Depressive Behavior via Neuron–Microglia Interactions

  2017cites this paper
• Valproate augmentation in a subgroup of patients with treatment-resistant unipolar depression

  2016influential citation
• Behandlung depressiver Störungen

  2016cites this paper
• Plasticity-augmented psychotherapy for refractory depressive and anxiety disorders.

  2016cites this paper
• PPT Polypharmazie in der Behandlung depressiver Störungen

  2014cites this paper
• Treatment of bipolar depression

  2013cites this paper
• Lithium, Thyroid Hormones and Further Augmentation Strategies in Treatment‐resistant Depression

  2013cites this paper
• Clinical Handbook for the Management of Mood Disorders

  2013cites this paper
• Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.

  2011cites this paper
• Microinjection of valproic acid into the ventrolateral orbital cortex exerts an antidepressant-like effect in the rat forced swim test.

  2011cites this paper
• Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study.

  2009cites this paper
• Polypharmazie in der Behandlung depressiver Störungen

  2009cites this paper
• Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: An open-label study

  2009cites this paper
• Anticonvulsants in the Treatment of Major Depressive Disorder: An Overview

  2009cites this paper
• Does acute treatment with sedatives/hypnotics for anxiety in depressed patients affect suicide risk? A literature review.

  2008cites this paper
• The effectiveness of anticonvulsants in psychiatric disorders

  2008cites this paper
• Role of Antiepileptic Drugs in the Treatment ofMajor Depressive Disorder

  2008cites this paper
• The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.

  2007cites this paper
• Dans le trouble de l ’ humeur bipolaire , on admet aujourd ’ hui que le degré de morbidité et les enjeux théra-peutiques qui y sont associés tiennent davantage aux épi-sodes dépressifs qu ’ aux épisodes maniaques

  2007cites this paper
• Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.

  2007cites this paper
• Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study.

  2007cites this paper
• Suicidality and Antiepileptic Drugs

  2007cites this paper
• Cytoskeleton of hippocampal neurons as a target for valproic acid in an experimental model of depression.

  2007cites this paper
• Phenytoin as an augmentation for SSRI failures: a small controlled study.

  2006cites this paper
• Melancholia: The Diagnosis, Pathophysiology and Treatment of Depressive Illness

  2006cites this paper
• Effects of chronic administration of olanzapine, amitriptyline, haloperidol or sodium valproate in naive and anhedonic rats.

  2006cites this paper
• Traitement pharmacologique des dépressions bipolaires: Bipolar depression : a review of current therapeutic strategies

  2006cites this paper
• Therapeutic Monitoring of Valproate in Psychiatry: How Far Have We Progressed?

  2006cites this paper
• [Bipolar depression: a review of current therapeutic strategies].

  2006cites this paper
• Phenytoin: an anti-bipolar anticonvulsant?

  2006cites this paper
• Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorder.

  2005cites this paper
• Anticonvulsants in bipolar disorder

  2005cites this paper
• GABA and glutamate systems as therapeutic targets in depression and mood disorders

  2005cites this paper
• Divalproex in the treatment of bipolar depression: a placebo-controlled study.

  2005cites this paper
• Beyond Monoamines: Glutamatergic Function in Mood Disorders

  2005cites this paper
• Treatment-Refractory Depression

  2004cites this paper
• El papel de los eutimizantes en la profilaxis de recaídas y recurrencias de la depresión

  2004cites this paper
• [Valpromide, Valproic acid and removal of small intestine in the treatment of a chronic depression: a case report].

  2004cites this paper
• Exclusion Criteria Used in Antidepressant Efficacy Trials: Consistency Across Studies and Representativeness of Samples Included

  2004influential citation
• Traitement d’une dépression résistante par substitution du Dépamide ® par la Dépakine ® chez une patiente avec résection du grêle

  2004cites this paper
• Valproate for acute mood episodes in bipolar disorder.

  2003cites this paper
• An open-label pilot study of divalproex sodium for posttraumatic stress disorder related to childhood abuse.

  2003cites this paper
• Baclofen Treatment for Chronic Posttraumatic Stress Disorder

  2003cites this paper
• Avoiding Drug-Induced Switching in Patients with Bipolar Depression

  2003cites this paper
• New uses for lithium and anticonvulsants.

  2003cites this paper
• Neurobiologia do transtorno de humor bipolar e tomada de decisão na abordagem psicofarmacológica

  2003cites this paper
• Redefining mood stabilization.

  2003cites this paper
• Valproinsäure in der Behandlung des manischen Syndroms und in der Prophylaxe bipolarer affektiver Störungen

  2002cites this paper
• Gabapentin augmentation therapy in bipolar depression.

  2002cites this paper
• Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study.

  2002cites this paper
• Geschichtliche Entwicklung des Einsatzes von Valproinsäure in der Psychiatrie

  2002cites this paper
• The Role of Divalproex in the Treatment of Bipolar Disorder

  2002cites this paper
• Symptom Severity and Exclusion From Antidepressant Efficacy Trials

  2002cites this paper
• Contemporary Neuropsychiatry

  2001cites this paper
• Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression.

  2001cites this paper
• Perspectives on the use of anticonvulsants in the treatment of bipolar disorder.

  2001cites this paper
• [Brief history of the development of valproate in bipolar disorders].

  2001cites this paper
• Anticonvulsants in the treatment of mood disorders: assessing current and future roles

  2001cites this paper
• Retrospective Analysis of Serum Valproate Levels and Need for an Antidepressant Drug

  2001cites this paper
• Antiepileptic Drugs in the Treatment of Psychiatric Diseases

  2001cites this paper
• The Impact of Mood Stabilizers on Suicide in Bipolar Disorder: A Comparative Analysis

  2000cites this paper
• Neurochemical and metabolic aspects of antidepressants: an overview.

  2000cites this paper
• Comprehensive review of the psychiatric uses of valproate.

  2000cites this paper
• Impairment of GABAergic transmission in depression: new insights from neuroimaging studies.

  2000cites this paper
• Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression.

  2000cites this paper
• Bipolar depression: pharmacotherapy and related therapeutic strategies.

  2000cites this paper
• Valproate use in psychiatry: A focus on bipolar illness

  1999cites this paper
• Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy

  1999cites this paper
• Neuroendocrine challenge studies of serotonin and gaba function in mania and in the mechanism of action of the mood stabilizer divalproex sodium

  1999cites this paper
• Reduced Cortical g -Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy

  1999cites this paper
• Divalproex in Posttraumatic Stress Disorder: An Open-Label Clinical Trial

  1999cites this paper
• Mood-stabilizing drugs in depression.

  1999cites this paper
• Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy.

  1999cites this paper
• Wirksamkeitsprädiktoren für Phasenprophylaktika (Stimmungsstabilisierer) bei bipolaren affektiven Störungen

  1999cites this paper
• [Predictors of response to phase prophylactics (mood stabilizers) in bipolar affective disorders].

  1999cites this paper
• Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?

  1999cites this paper
• Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate

  1998cites this paper
• The Efficacy and Use of Anticonvulsants in Mood Disorders

  1998cites this paper
• Anticonvulsants and antipsychotics in the treatment of bipolar disorder.

  1998cites this paper
• Efficacy of Divalproex Sodium in Patients with Panic Disorder and Mood Instability Who Have Not Responded to Conventional Therapy

  1998cites this paper
• Divalproex Sodium Attenuates Growth Hormone Response to Baclofen in Healthy Human Males

  1998influential citation
• The use of anticonvulsants to augment antidepressant medication.

  1998influential citation
• Drug-Induced Switching in Bipolar Disorder

  1997cites this paper